Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daichi Sugahara
Observed name:
D. Sugahara
Institution:
University of Tokyo Hospital
Observed institution:
University of Tokyo Hospital
ORCID:
0009-0001-8051-4137
Observed ORCID:
0009-0001-8051-4137
OpenAlex ID:
A5106591749
Stereotactic Ablative Radiation Therapy for Sacral Bone Metastasis in Recurrent Type A Thymoma: A Two-Year Follow-Up Demonstrating Pain Reduction and Local Control
2024
·
Atsuto Katano
, Daichi Sugahara
, et al.
·
Cureus
·
4
PDF
Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study
2026
·
Akiko Oka
, Hideomi Yamashita
, et al.
·
Journal of Radiation Research
PDF
36.25 Gy versus 40 Gy in five fractions of curative stereotactic body radiotherapy for prostate cancer: a propensity score-matched analysis
2026
·
Hideomi Yamashita
, Daichi Sugahara
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy
2026
·
D. Sugahara
, H. Yamashita
, et al.
·
Clinical Oncology
Diabetes mellitus as a potential risk factor for severe late toxicity after stereotactic body radiotherapy for prostate cancer: a large single-institution cohort study
2026
·
Daichi Sugahara
, Hideomi Yamashita
, et al.
·
Journal of Radiation Research
Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan
2026
·
Daichi Sugahara
, Keiko Nemoto Murofushi
, et al.
·
Japanese Journal of Clinical Oncology
Four Cases of Single-Fraction Stereotactic Body Radiation Therapy for Prostate Cancer
2024
·
Ayane Yasui
, Subaru Sawayanagi
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
7
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type